UPClytics
ENDE
Sign inStart trial
View all cases

UPC CFI 192/2025

Mar 3, 2025·EP4241767 Unitary patent · NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

Follow
Case details
Status
Case Closed (Withdrawn)
Action
Infringement
Category
Main infringement action
Parties
Claimants
Representatives
Respondents
Representatives
Division
The Hague LD
Judges
Technology
  • Chemistry
    Pharmaceuticals
Language
English
First decided
Aug 25, 2026
EPO Opposition
  • ModernaTX, Inc.Withdrawn2025-04-29
  • Merck Sharp & Dohme (UK) LimitedWithdrawn2025-07-23
  • Arrowhouse GmbHAdmissible2025-07-23
  • Keltie LLPAdmissible2025-07-23
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Infringement foundMedian days to first decision
All UPC53% (62/117)124
The Hague LDLockedLocked
Judge Edger BrinkmanLockedLocked
Judge Margot KokkeLockedLocked
Judge Samuel GranataLockedLocked
Judge Xavier Dorland-GalliotLockedLocked

At the UPC: Genevant Sciences GmbH (9 cases)·Moderna Group (20 cases)

Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patent

This dispute contains 3 other proceedings

UPC APP 18039/2025·UPC APP 25212/2025·UPC APP 27016/2025

3 other defendants litigating the same or a related patent

UPC CFI 2562/2026·UPC CFI 2566/2026·UPC CFI 607/2025

Start a free trial to see how each one ended.

More cases: The Hague LD·2025

Decisions
  • 2026-08-25
    InfringementPublic

    Summary: The Hague Local Division allowed the joint withdrawal, under R.265.1 RoP, of Genevant Sciences/Arbutus Biopharma's infringement action (UPC-CFI-192/2025) against fifteen Moderna entities and Moderna's counterclaim for revocation (UPC-CFI-607/2025) of EP4241767, following a settlement between the parties, declared both proceedings closed, and dismissed the parties' joint request for reimbursement of court fees under R.370.9(b) RoP because the proceedings had already entered the interim phase.

    Show the legal issues (2)
    • joint withdrawal of an infringement action and a revocation counterclaim following settlement (R.265.1 RoP)
    • reimbursement of court fees under R.370.9(b)/(e) RoP denied because the proceedings had already entered the interim phase
Documents
Document titleDatePublic
Publication of order2026-08-25Not public
Case closed2026-08-25Not public
Order2026-08-25Not public
Order2026-08-25Public
Hearing recording reference document2026-03-09Not public
Receipt2026-03-04Not public
Cover sheet2026-03-04Not public
Application document Claimant2026-03-04Not public
Receipt2026-02-27Not public
Cover sheet2026-02-27Not public
Document Defendant2026-02-27Not public
Communication2026-02-27Not public
Receipt2026-02-26Not public
Cover sheet2026-02-26Not public
Fee2026-02-26Not public
Application document Defendant2026-02-26Not public
Receipt2026-02-19Not public
Cover sheet2026-02-19Not public
Exhibit Claimant2026-02-19Not public
Exhibit Claimant2026-02-19Not public
Order2026-02-12Not public
Order2026-02-12Public
Receipt2026-01-21Not public
Cover sheet2026-01-21Not public
Other document Claimant2026-01-21Not public
Receipt2026-01-21Not public
Cover sheet2026-01-21Not public
Other document Defendant2026-01-21Not public
Interim procedure opened2026-01-14Not public
Written procedure closed2026-01-14Not public
Cover sheet2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Statement of rejoinder2025-11-10Not public
Receipt2025-11-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
Exhibit A114 - Maier 2013 - Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery o2025-09-10Not public
Exhibit A111 - Schlich 2021 - Cytosolic delivery of nucleic acids The case of ionizable lipid2025-09-10Not public
Exhibit A105 - US 61-222.469 - FBD-T 65 P12025-09-10Not public
Exhibit A099 - Register extract of FBD-T 662025-09-10Not public
Exhibit A116 - Moderna Biotech Spain documentation of Spikevax supply and invoicing to EU states2025-09-10Not public
Exhibit A110 - Semple 2010 - Rational design of cationic lipids for siRNA delivery - supplementary information2025-09-10Not public
Exhibit A102 - US 61-242.761 - FBD-T 63 P32025-09-10Not public
Exhibit A098 - Prof. Dr. Ir. De Geest declaration (including annexes)2025-09-10Not public
Exhibit A096 - Song 1997 - Characterization of Cationic liposome-mediated Transfer In Vivo by Intravenous Administration2025-09-10Not public
Exhibit A118 - Moderna Italy webpage2025-09-10Not public
Exhibit A101 - US 61-234.045 - FBD-T 63 P22025-09-10Not public
Exhibit A107 - US 61-159.788 - FBD-T 62 P12025-09-10Not public
Exhibit A117 - Belgium trade register registrations for Moderna Biotech Spain - Moderna Switzerland and Moderna Netherla2025-09-10Not public
Exhibit A108 - US 61-231.579 - FBD-T 62 P22025-09-10Not public
Exhibit A104 - US 61-258.848 - FBD-T 63 P52025-09-10Not public
Exhibit A106 - US 61-222.464 - FBD-T 67 P12025-09-10Not public
Exhibit A103 - US 61-251.999 - FBD-T 63 P42025-09-10Not public
Exhibit A112 - Coelho 2013 - Safety and efficacy of RNAi therapy for transthyretin amyloidosis2025-09-10Not public
Exhibit A092 - EP 767 Claim requests (tracked changes version)2025-09-10Not public
Exhibit A093 - Heyes 2005 - Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids2025-09-10Not public
Exhibit A097 - Sabnis 2018 - A novel amino lipid series for mRNA delivery - improved endosomal escape and sustained phar2025-09-10Not public
Reply to SoD + Defence to CC + App to Amend2025-09-10Not public
Exhibit A100 - US 61-175.777 - FBD-T 63 P12025-09-10Not public
Exhibit A109 - Semple 2010 - Rational design of cationic lipids for siRNA delivery2025-09-10Not public
Exhibit A094 - Jeffs 2005 - A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA2025-09-10Not public
Exhibit A113 - Lv 2006 - Toxicity of cationic lipids and cationic polymers in gene delivery2025-09-10Not public
Exhibit A095 - Bajaj 2007 - Effect of the headgroup variation on the gene transfer properties of cholesterol based catio2025-09-10Not public
Exhibit A091 - EP 767 Claim requests (clean version)2025-09-10Not public
Exhibit A115 - Arbutus - Genevant Cross-License Agreement 2018 (SEC version)2025-09-10Not public
Panel-Appointment2025-08-18Not public
Headnote-and-Keywords2025-08-18Not public
Outcome of the Order2025-08-18Not public
Confirmation of PO Order2025-08-18Public
R.37.2 order2025-08-15Public
Joint statement regarding bifurcation2025-08-13Not public
Joint statement regarding bifurcation2025-08-13Not public
Statement regarding security pursuant to R.158 RoP2025-08-11Not public
R.37.22025-08-06Not public
Hearing-Dates2025-08-06Not public
R.282025-08-06Public
Hearing-Dates2025-08-06Not public
opportunity to comment2025-08-04Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Acknowledgement-of-lodging2025-07-25Not public
Receipt2025-07-25Not public
Reference to response of Genevant2025-07-23Not public
R.262.2 Application2025-07-23Not public
Exhibit A0882025-07-23Not public
Exhibit A090 - confidential2025-07-23Not public
Confidential Reply Security for Costs2025-07-23Not public
Exhibit A090 - confidential2025-07-23Not public
Confidential Reply Security for Costs2025-07-23Not public
Exhibit A0892025-07-23Not public
Exhibit FBD 052025-07-17Not public
25-06-06_-_EP_254_and_EP_767_-_Request_for_Panel_Review_-_Moderna_vs_Genevant_-_App_No_33094 _20252025-07-17Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
opportunity to comment2025-07-09Not public
Template-Order2025-07-09Not public
Receipt2025-07-09Not public
Exhibit FBD 122025-07-09Not public
Exhibit FBD 112025-07-09Not public
25-07-07_-_UPC1_EP767_UPC_DRAFT_-_Request_security_pursuant_to_R158(307434330.1)2025-07-09Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence2025-07-08Not public
Exhibit FBD 42025-07-08Not public
Exhibit FBD-T 462025-07-08Not public
Exhibit FBD-T 662025-07-08Not public
Exhibit FBD-T 582025-07-08Not public
Exhibit FBD-T 42025-07-08Not public
Exhibit FBD-T 212025-07-08Not public
Exhibit FBD 82025-07-08Not public
Exhibit FBD-T 642025-07-08Not public
Exhibit FBD-T 592025-07-08Not public
Exhibit FBD-T 192025-07-08Not public
Exhibit FBD-T 162025-07-08Not public
Exhibit FBD-T 62025-07-08Not public
Exhibit FBD-T 472025-07-08Not public
Exhibit FBD-T 102025-07-08Not public
Exhibit FBD-T 362025-07-08Not public
Exhibit FBD 92025-07-08Not public
Exhibit FBD-T 82025-07-08Not public
Exhibit FBD 112025-07-08Not public
Exhibit FBD-T 232025-07-08Not public
Exhibit FBD-T 442025-07-08Not public
Exhibit FBD-T 682025-07-08Not public
Exhibit FBD-T 482025-07-08Not public
Exhibit FBD-T 92025-07-08Not public
Exhibit FBD-T 272025-07-08Not public
Exhibit FBD 32025-07-08Not public
Exhibit FBD 7 - Part 5 of 52025-07-08Not public
Exhibit FBD 122025-07-08Not public
Exhibit FBD-T 182025-07-08Not public
EP 767 - Moderna Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Exhibit FBD-T 252025-07-08Not public
Exhibit FBD-T 322025-07-08Not public
Exhibit FBD-T 312025-07-08Not public
Exhibit FBD-T 372025-07-08Not public
Exhibit FBD-T 632025-07-08Not public
Exhibit FBD-T 12025-07-08Not public
Exhibit FBD-T 262025-07-08Not public
Exhibit FBD-T 222025-07-08Not public
Exhibit FBD 7 - Part 2 of 52025-07-08Not public
Exhibit FBD-T 602025-07-08Not public
Exhibit FBD-T 32025-07-08Not public
Exhibit FBD-T 302025-07-08Not public
Exhibit FBD-T 562025-07-08Not public
Exhibit FBD-T 342025-07-08Not public
Exhibit FBD-T 292025-07-08Not public
Exhibit FBD-T 332025-07-08Not public
Exhibit FBD-T 612025-07-08Not public
Exhibit FBD-T 112025-07-08Not public
Exhibit FBD-T 672025-07-08Not public
Exhibit FBD 7 - Part 3 of 52025-07-08Not public
Exhibit FBD-T 652025-07-08Not public
Exhibit FBD-T 432025-07-08Not public
Exhibit FBD-T 692025-07-08Not public
Exhibit FBD-T 542025-07-08Not public
Exhibit FBD-T 242025-07-08Not public
Exhibit FBD-T 402025-07-08Not public
Exhibit FBD-T 502025-07-08Not public
Exhibit FBD 62025-07-08Not public
Exhibit FBD-T 282025-07-08Not public
Exhibit FBD-T 72025-07-08Not public
Exhibit FBD-T 352025-07-08Not public
Exhibit FBD 7 - Part 1 of 52025-07-08Not public
Exhibit FBD-T 492025-07-08Not public
Exhibit FBD-T 412025-07-08Not public
Exhibit FBD-T 132025-07-08Not public
Exhibit FBD-T 702025-07-08Not public
Exhibit FBD-T 532025-07-08Not public
Exhibit FBD-T 172025-07-08Not public
Exhibit FBD-T 572025-07-08Not public
Exhibit FBD-T 382025-07-08Not public
Exhibit FBD-T 552025-07-08Not public
Exhibit FBD-T 512025-07-08Not public
Exhibit FBD-T 202025-07-08Not public
Exhibit FBD 7 - Part 4 of 52025-07-08Not public
Exhibit FBD-T 142025-07-08Not public
Exhibit FBD-T 452025-07-08Not public
Exhibit FBD 102025-07-08Not public
Exhibit FBD-T 52025-07-08Not public
Exhibit FBD-T 152025-07-08Not public
Exhibit FBD-T 22025-07-08Not public
Exhibit FBD 52025-07-08Not public
Exhibit FBD-T 622025-07-08Not public
Exhibit FBD-T 422025-07-08Not public
Exhibit FBD-T 522025-07-08Not public
Exhibit FBD-T 392025-07-08Not public
Exhibit FBD-T 122025-07-08Not public
Outcome of the Order2025-06-04Not public
rectification2025-06-04Public
Response to request for rectification2025-06-02Not public
Response to request for rectification2025-06-02Not public
opportunity to comment2025-05-28Not public
Receipt2025-05-27Not public
25-05-27_-_Request_for_Rectification_-_Moderna_vs_Genevant_-_CFI_191_2025_and_CFI_192_20252025-05-27Not public
Preliminary_Objection_DecisionOutcome2025-05-23Not public
R.19 order2025-05-23Public
Preliminary_Objection_DecisionOutcome2025-05-23Not public
R.19 order2025-05-23Public
Comment-On-Preliminary-Objection2025-05-08Not public
Comment on Preliminary objection2025-05-08Not public
Exhibit A087 - Notice 2025 European tender2025-05-08Not public
Comment-On-Preliminary-Objection2025-05-07Not public
Exhibit A087 - Notice 2025 European tender2025-05-07Not public
Comment on Preliminary objection2025-05-07Not public
Notification Of Service2025-05-06Not public
2025_05_05 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Norway AS2025-05-06Not public
Acknowledgement of access to case2025-05-05Not public
Acknowledgement of access to case2025-05-05Not public
Acknowledgement of access to case2025-05-05Not public
Notification Of Service2025-05-01Not public
2025-04-29 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of service Sweden2025-05-01Not public
Notification Of Service2025-05-01Not public
2025_03_24 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Switzerland GmbH2025-05-01Not public
Preliminary-Objection2025-04-25Not public
Notification Of Service2025-04-25Not public
2025_23_04 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Inc.2025-04-25Not public
Preliminary Objections of Defendants 1-142025-04-24Not public
Exhibit FBD 22025-04-24Not public
Acknowledgement of access to case2025-04-24Not public
Preliminary-Objection2025-04-23Not public
Preliminary objection on behalf of Moderna UK2025-04-22Not public
Notification Of Service2025-04-22Not public
2025_04_21 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service ModernaTX Inc2025-04-22Not public
Headnote-and-Keywords2025-04-17Not public
this order is issued in this workflow for technical reasons only2025-04-17Public
Outcome of the Order2025-04-17Not public
this order is issued in this workflow for technical reasons only2025-04-17Public
Outcome of the Order2025-04-17Not public
Receipt2025-04-17Not public
setting deadline for SoD2025-04-17Public
Template-Order2025-04-17Not public
Further response re deadline extension2025-04-17Not public
Receipt2025-04-17Not public
R9 Request re service Moderna Inc and ModernaTX Inc2025-04-17Not public
Exhibit A086 - Letter re representation MLL of Moderna Inc ModernaTX Inc2025-04-17Not public
Receipt2025-04-15Not public
Response re request for deadline extension2025-04-15Not public
Receipt2025-04-14Not public
R 9 aplication reply to R 9 request2025-04-14Not public
opportunity to comment2025-04-10Not public
Template-Order2025-04-10Not public
opportunity to comment2025-04-09Not public
Receipt2025-04-09Not public
Request for deadline extension2025-04-09Not public
Exhibit FBD 12025-04-09Not public
Acknowledgement of access to case2025-04-08Not public
Acknowledgement of access to case2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_21 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Belgium S.R.L.2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_25 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna France SASU2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_27 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Italy S.R.L.2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_21 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Germany GmbH2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_28 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Netherlands B.V.2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_21 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Biotech UK Limited2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_27 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Portugal Unipessoal LDA2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_26 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Denmark ApS2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_26 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Biotech Spain SL2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_25 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Poland SP. Z.O.O.2025-04-08Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-28Not public
Acknowledgement of access to case2025-03-24Not public
Panel-Appointment2025-03-17Not public
communicationCheck2025-03-17Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Document from EPO2025-03-11Not public
communicationCheck2025-03-11Not public
Document from EPO2025-03-11Not public
communicationCheck2025-03-11Not public
Document from EPO2025-03-11Not public
Panel-Appointment2025-03-06Not public
EPO-Request-for-case-pending2025-03-06Not public
Receipt2025-03-06Not public
Formal-checks_Notification-of-positive-outcome2025-03-06Not public
Exhibit A054 - EC Draft framework contract2025-03-05Not public
Exhibit A046 - Modernatx website2025-03-05Not public
Exhibit A077 - Moderna CH service agreement TR2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A069 - Moderna France trade register2025-03-05Not public
Exhibit A049.04 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A034 - EP 4241767 A22025-03-05Not public
Exhibit A070 - Moderna Italy trade register2025-03-05Not public
Exhibit A039 - Modernas RD Day Presentation 17 September 20202025-03-05Not public
Exhibit A032 - Intention to grant of 28 August 20242025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A007 - Zimmerman 20062025-03-05Not public
Exhibit A049.03 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A017 - Certificate of change of name Tekmira to Arbutus2025-03-05Not public
Exhibit A004 - Proof of payment NL77INGB0675829062_28-02-2025_28-02-20252025-03-05Not public
Exhibit A026 - Transmission of certificate of 18 November 20242025-03-05Not public
Exhibit A052 - Moderna press release 2025 tender2025-03-05Not public
Exhibit A053 - Moderna Inc. press release Chantal-Friebertshauser 20222025-03-05Not public
Exhibit A031 - Letter amendments before examination of 2 April 20242025-03-05Not public
Exhibit A050 - EX - PA EC Moderna CH 20212025-03-05Not public
Exhibit A001 - National register excerpts2025-03-05Not public
Exhibit A063 - Moderna ES trade register2025-03-05Not public
Exhibit A033 - Decision to grant of 29 September 20242025-03-05Not public
Exhibit A049.06 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A064 - Moderna Netherlands Madrid2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A072 - Moderna Denmark trade register2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A055 - Moderna NL Trade Register2025-03-05Not public
Exhibit A045 - Domain registrations Moderna2025-03-05Not public
Exhibit A015.04 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A015.02 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A047 - Modernacovid19global website2025-03-05Not public
Exhibit A019 - US20090154350P of 20 February 20092025-03-05Not public
Exhibit A015.03 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A030 - Amended claims of 2 April 20242025-03-05Not public
Exhibit A069 - Moderna France trade register2025-03-05Not public
Exhibit A015.01 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A049.08 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A081 - Moderna ROVI 2022 press release2025-03-05Not public
Exhibit A015.09 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A065 - Moderna Poland trade register2025-03-05Not public
Exhibit A064 - Moderna Netherlands Madrid2025-03-05Not public
Exhibit A066 - Moderna UK trade register2025-03-05Not public
Exhibit A049.02 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A003 - EP 4 241 767 B12025-03-05Not public
Exhibit A078 - Moderna press release Lonza NL 20212025-03-05Not public
Exhibit A024 - Request for unitary effect of 31 October 20242025-03-05Not public
Exhibit A014 - Samaridou 20202025-03-05Not public
Exhibit A060 - Moderna NL tender notice Poland PL2025-03-05Not public
Exhibit A071 - Moderna Belgium trade register2025-03-05Not public
Exhibit A079 - Lonza press release 20212025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A036 - Moderna press release 23 August 20242025-03-05Not public
Exhibit A057 - Moderna NL Hungary contract 2023 HUN2025-03-05Not public
Exhibit A073 - Moderna Sweden trade register2025-03-05Not public
Exhibit A008 - Press release Tekmira and Alnylam Settlement2025-03-05Not public
Exhibit A038 - Transcript Moderna Vaccines Day 14 April 2021 selection2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A067 - Moderna UK Annual report 20232025-03-05Not public
Exhibit A059 - Moderna NL PL tender notice PL2025-03-05Not public
Exhibit A085 - Moderna Inc 2024 annual report p. 1152025-03-05Not public
Exhibit A023 - US20090234098P of 14 August 20092025-03-05Not public
Exhibit A061 - Spikevax Lauer Taxe Germany2025-03-05Not public
Exhibit A022 - US20090225898P of 15 July 20092025-03-05Not public
Exhibit A025 - Registration of unitary effect of 13 November 20242025-03-05Not public
Exhibit A016 - Assignment from Alnylam to Tekmira2025-03-05Not public
Statement of Claim EP 767_signed2025-03-05Not public
Exhibit A062 - mRESVIA Lauer Taxe Germany2025-03-05Not public
Exhibit A002 - Confirmatory declaration Genevant-Arbutus2025-03-05Not public
Exhibit A056 - Moderna NL Annual Report 20232025-03-05Not public
Exhibit A027 - Request for application and claims of 24 May 20232025-03-05Not public
Exhibit A005B - Arbutus Biopharma Corporation trade register excerpt2025-03-05Not public
Exhibit A082 - Moderna RECIPHARM 2020 press release2025-03-05Not public
Exhibit A059 - Moderna NL PL tender notice PL2025-03-05Not public
Exhibit A018 - US20080113179P of 10 November 20082025-03-05Not public
Exhibit A049.01 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A063 - Moderna ES trade register2025-03-05Not public
Exhibit A084 - Moderna 2023 annual report p. 1192025-03-05Not public
Exhibit A012 - Cross CEN News 20212025-03-05Not public
Exhibit A068 - Moderna Germany trade register2025-03-05Not public
Exhibit A074 - Moderna Norway trade register2025-03-05Not public
Exhibit A040 - Modernas RD Day Transcript 17 September 2020 selection2025-03-05Not public
Exhibit A010 - Corbett Nature Review 20202025-03-05Not public
Exhibit A035 - mRESVIA SmPC2025-03-05Not public
Exhibit A073 - Moderna Sweden trade register2025-03-05Not public
Exhibit A083 - Moderna RECIPHARM 2021 press release2025-03-05Not public
Exhibit A075 - Moderna Portugal trade register2025-03-05Not public
Exhibit A011 - Regalado MIT Technology 20202025-03-05Not public
Exhibit A021 - US20090185438P of 9 June 20092025-03-05Not public
Exhibit A028 - European search opinion of 5 October 20232025-03-05Not public
Exhibit A049.05 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A009 - Shaun Ryan (Moderna) Declaration2025-03-05Not public
Exhibit A041 - Moderna Inc trade register excerpt2025-03-05Not public
Exhibit A065 - Moderna Poland trade register2025-03-05Not public
Exhibit A015.07 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A051 - EC press release 2025 tender2025-03-05Not public
Exhibit A072 - Moderna Denmark trade register2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A015.05 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A015.10 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A058 - Moderna NL Hungary contract 20242025-03-05Not public
Exhibit A043 - Moderna Inc 2022 press release2025-03-05Not public
Exhibit A055 - Moderna NL Trade Register2025-03-05Not public
Exhibit A029 - D2 - US6320017B12025-03-05Not public
Exhibit A015.06 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A076 - Moderna Lonza press release 20202025-03-05Not public
Exhibit A037 - EMA assesment report mRESVIA2025-03-05Not public
Exhibit A015.08 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A013 - Clancy S and Brown W (2008) Translation DNA to mRNA to Protein2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A006 - Spikevax SmPC2025-03-05Not public
Exhibit A015.11 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A080 - Moderna ROVI 2020 press release2025-03-05Not public
Exhibit A057 - Moderna NL Hungary contract 2023 HUN2025-03-05Not public
Exhibit A068 - Moderna Germany trade register2025-03-05Not public
Exhibit A015.13 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A015.12 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A048 - Moderna Switzerland trade register2025-03-05Not public
Exhibit A060 - Moderna NL tender notice Poland PL2025-03-05Not public
Exhibit A042 - Moderna Inc 2023 annual report exhibit 21 12025-03-05Not public
Exhibit A005A - Genevant Sciences trade register2025-03-05Not public
Exhibit A074 - Moderna Norway trade register2025-03-05Not public
Exhibit A075 - Moderna Portugal trade register2025-03-05Not public
Exhibit A049.07 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A020 - US20090171439P of 21 April 20092025-03-05Not public
Exhibit A044 - ModernaTX trade register excerpt2025-03-05Not public
Formal-checks_Request-for-correction2025-03-04Not public
Acknowledgement-of-lodging2025-03-03Not public
Exhibit A060 - Moderna NL tender notice Poland PL2025-03-03Not public
Exhibit A015.05 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A056 - Moderna NL Annual Report 20232025-03-03Not public
Exhibit A049.07 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A081 - Moderna ROVI 2022 press release2025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A059 - Moderna NL PL tender notice PL2025-03-03Not public
Exhibit A067 - Moderna UK Annual report 20232025-03-03Not public
Exhibit A079 - Lonza press release 20212025-03-03Not public
Exhibit A007 - Zimmerman 20062025-03-03Not public
Exhibit A028 - European search opinion of 5 October 20232025-03-03Not public
Exhibit A060 - Moderna NL tender notice Poland PL2025-03-03Not public
Exhibit A049.02 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A064 - Moderna Netherlands Madrid2025-03-03Not public
Exhibit A015.12 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A015.03 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A046 - Modernatx website2025-03-03Not public
Exhibit A061 - Spikevax Lauer Taxe Germany2025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A074 - Moderna Norway trade register2025-03-03Not public
Exhibit A076 - Moderna Lonza press release 20202025-03-03Not public
Exhibit A069 - Moderna France trade register2025-03-03Not public
Exhibit A040 - Modernas RD Day Transcript 17 September 2020 selection2025-03-03Not public
20250303 Statement of Claim EP 767_signed2025-03-03Not public
Exhibit A008 - Press release Tekmira and Alnylam Settlement2025-03-03Not public
Exhibit A004 - Proof of payment NL77INGB0675829062_28-02-2025_28-02-20252025-03-03Not public
Exhibit A084 - Moderna 2023 annual report p. 1192025-03-03Not public
Exhibit A012 - Cross CEN News 20212025-03-03Not public
Exhibit A052 - Moderna press release 2025 tender2025-03-03Not public
Exhibit A015.06 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A043 - Moderna Inc 2022 press release2025-03-03Not public
Exhibit A039 - Modernas RD Day Presentation 17 September 20202025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A063 - Moderna ES trade register2025-03-03Not public
Exhibit A015.10 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A072 - Moderna Denmark trade register2025-03-03Not public
Exhibit A049.08 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A027 - Request for application and claims of 24 May 20232025-03-03Not public
Exhibit A015.01 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A005A - Genevant Sciences trade register2025-03-03Not public
Exhibit A023 - US20090234098P of 14 August 20092025-03-03Not public
Exhibit A075 - Moderna Portugal trade register2025-03-03Not public
Exhibit A065 - Moderna Poland trade register2025-03-03Not public
Exhibit A049.05 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A030 - Amended claims of 2 April 20242025-03-03Not public
Exhibit A047 - Modernacovid19global website2025-03-03Not public
Exhibit A013 - Clancy S and Brown W (2008) Translation DNA to mRNA to Protein2025-03-03Not public
Exhibit A062 - mRESVIA Lauer Taxe Germany2025-03-03Not public
Exhibit A057 - Moderna NL Hungary contract 2023 HUN2025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A001 - National register excerpts2025-03-03Not public
Exhibit A018 - US20080113179P of 10 November 20082025-03-03Not public
Exhibit A016 - Assignment from Alnylam to Tekmira2025-03-03Not public
Exhibit A015.08 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A068 - Moderna Germany trade register2025-03-03Not public
Exhibit A025 - Registration of unitary effect of 13 November 20242025-03-03Not public
Exhibit A015.09 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A073 - Moderna Sweden trade register2025-03-03Not public
Exhibit A015.11 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A032 - Intention to grant of 28 August 20242025-03-03Not public
Exhibit A049.04 - APA EC Moderna CH 20202025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A015.13 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A006 - Spikevax SmPC2025-03-03Not public
Exhibit A042 - Moderna Inc 2023 annual report exhibit 21 12025-03-03Not public
Exhibit A033 - Decision to grant of 29 September 20242025-03-03Not public
Exhibit A078 - Moderna press release Lonza NL 20212025-03-03Not public
Exhibit A021 - US20090185438P of 9 June 20092025-03-03Not public
Exhibit A057 - Moderna NL Hungary contract 2023 HUN2025-03-03Not public
Exhibit A083 - Moderna RECIPHARM 2021 press release2025-03-03Not public
Exhibit A009 - Shaun Ryan (Moderna) Declaration2025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A055 - Moderna NL Trade Register2025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A063 - Moderna ES trade register2025-03-03Not public
Exhibit A014 - Samaridou 20202025-03-03Not public
Exhibit A077 - Moderna CH service agreement TR2025-03-03Not public
Exhibit A070 - Moderna Italy trade register2025-03-03Not public
Exhibit A022 - US20090225898P of 15 July 20092025-03-03Not public
Exhibit A059 - Moderna NL PL tender notice PL2025-03-03Not public
Exhibit A044 - ModernaTX trade register excerpt2025-03-03Not public
Exhibit A015.07 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A019 - US20090154350P of 20 February 20092025-03-03Not public
Exhibit A015.02 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A054 - EC Draft framework contract2025-03-03Not public
Exhibit A069 - Moderna France trade register2025-03-03Not public
Exhibit A005B - Arbutus Biopharma Corporation trade register excerpt2025-03-03Not public
Exhibit A064 - Moderna Netherlands Madrid2025-03-03Not public
Exhibit A037 - EMA assesment report mRESVIA2025-03-03Not public
Exhibit A026 - Transmission of certificate of 18 November 20242025-03-03Not public
Exhibit A073 - Moderna Sweden trade register2025-03-03Not public
Exhibit A031 - Letter amendments before examination of 2 April 20242025-03-03Not public
Exhibit A055 - Moderna NL Trade Register2025-03-03Not public
Exhibit A051 - EC press release 2025 tender2025-03-03Not public
Exhibit A050 - EX - PA EC Moderna CH 20212025-03-03Not public
Exhibit A065 - Moderna Poland trade register2025-03-03Not public
Exhibit A048 - Moderna Switzerland trade register2025-03-03Not public
Exhibit A049.03 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A015.04 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A053 - Moderna Inc. press release Chantal-Friebertshauser 20222025-03-03Not public
Exhibit A010 - Corbett Nature Review 20202025-03-03Not public
Exhibit A080 - Moderna ROVI 2020 press release2025-03-03Not public
Exhibit A038 - Transcript Moderna Vaccines Day 14 April 2021 selection2025-03-03Not public
Exhibit A066 - Moderna UK trade register2025-03-03Not public
Exhibit A029 - D2 - US6320017B12025-03-03Not public
Exhibit A041 - Moderna Inc trade register excerpt2025-03-03Not public
Exhibit A049.01 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A082 - Moderna RECIPHARM 2020 press release2025-03-03Not public
Exhibit A068 - Moderna Germany trade register2025-03-03Not public
Exhibit A075 - Moderna Portugal trade register2025-03-03Not public
Exhibit A003 - EP 4 241 767 B12025-03-03Not public
Exhibit A071 - Moderna Belgium trade register2025-03-03Not public
Exhibit A049.06 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A036 - Moderna press release 23 August 20242025-03-03Not public
Exhibit A017 - Certificate of change of name Tekmira to Arbutus2025-03-03Not public
Exhibit A085 - Moderna Inc 2024 annual report p. 1152025-03-03Not public
Exhibit A045 - Domain registrations Moderna2025-03-03Not public
Exhibit A002 - Confirmatory declaration Genevant-Arbutus2025-03-03Not public
Exhibit A074 - Moderna Norway trade register2025-03-03Not public
Exhibit A011 - Regalado MIT Technology 20202025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A020 - US20090171439P of 21 April 20092025-03-03Not public
Exhibit A072 - Moderna Denmark trade register2025-03-03Not public
Exhibit A058 - Moderna NL Hungary contract 20242025-03-03Not public
Exhibit A024 - Request for unitary effect of 31 October 20242025-03-03Not public
Exhibit A034 - EP 4241767 A22025-03-03Not public